Suppr超能文献

基础核心启动子突变与慢性乙型肝炎病毒感染向肝硬化进展相关,而非与肝细胞癌相关。

Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection.

机构信息

Liver Research Unit, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 199, Tung Hwa North Road, Taipei 10591, Taiwan.

出版信息

Br J Cancer. 2012 Dec 4;107(12):2010-5. doi: 10.1038/bjc.2012.474. Epub 2012 Oct 18.

Abstract

BACKGROUND

As most cases of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) have concurrent cirrhosis, viral factors identified to be associated with HCC might be related to cirrhosis rather than HCC.

METHODS

Hepatitis B virus DNA levels, genotypes and precore/basal core promoter (BCP) mutants were compared between cirrhotic HCC and non-cirrhotic HCC patients. Age- and sex-matched case-control studies were performed to identify the risk factors.

RESULTS

Hepatitis B virus DNA levels showed no significant difference between non-cirrhotic HCC patients (n=20) and cirrhotic HCC patients (n=140) or 1 : 3 age- and sex-matched cirrhotic HCC patients (n=60), but genotype C and BCP mutant were significantly more prevalent in the latter than in the former. In multiple logistic regression, BCP mutant but not genotype C correlated significantly with the presence of cirrhosis in HCC patients. Compared with inactive carriers (n=60), non-cirrhotic HCC patients (n=20) had significantly higher HBV DNA levels but no difference in HBV genotypes and precore/BCP mutants. Furthermore, HBV DNA levels, the distribution of HBV genotypes and the prevalence of precore/BCP mutants all failed to show any significant difference between cirrhotic HCC patients (n=60) and cirrhotic patients without HCC (n=60).

CONCLUSION

Basal core promoter mutant is associated with progression to cirrhosis rather than HCC in chronic HBV infection.

摘要

背景

由于大多数乙型肝炎病毒(HBV)相关肝细胞癌(HCC)都伴有肝硬化,因此与 HCC 相关的病毒因素可能与肝硬化有关,而与 HCC 无关。

方法

比较了肝硬化 HCC 患者与非肝硬化 HCC 患者的乙型肝炎病毒 DNA 水平、基因型和前核心/基本核心启动子(BCP)突变体。进行了年龄和性别匹配的病例对照研究,以确定危险因素。

结果

乙型肝炎病毒 DNA 水平在非肝硬化 HCC 患者(n=20)与肝硬化 HCC 患者(n=140)或年龄和性别匹配的肝硬化 HCC 患者 1:3 (n=60)之间无显著差异,但基因型 C 和 BCP 突变体在后者中明显更常见。在多因素逻辑回归中,BCP 突变体而非基因型 C 与 HCC 患者的肝硬化存在显著相关。与非活动携带者(n=60)相比,非肝硬化 HCC 患者(n=20)的 HBV DNA 水平显著升高,但 HBV 基因型和前核心/BCP 突变体无差异。此外,肝硬化 HCC 患者(n=60)与无 HCC 的肝硬化患者(n=60)之间的 HBV DNA 水平、HBV 基因型分布和 BCP 突变体的流行率均无显著差异。

结论

在慢性 HBV 感染中,BCP 突变与进展为肝硬化有关,而与 HCC 无关。

相似文献

2
Different pre-S deletion patterns and their association with hepatitis B virus genotypes.
World J Gastroenterol. 2016 Sep 21;22(35):8041-9. doi: 10.3748/wjg.v22.i35.8041.
4
Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.
J Infect Dis. 2006 May 1;193(9):1258-65. doi: 10.1086/502978. Epub 2006 Apr 4.
8
Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment.
World J Gastroenterol. 2019 Oct 14;25(38):5883-5896. doi: 10.3748/wjg.v25.i38.5883.
10
Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.
J Natl Cancer Inst. 2008 Aug 20;100(16):1134-43. doi: 10.1093/jnci/djn243. Epub 2008 Aug 11.

引用本文的文献

1
High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy.
J Gastroenterol. 2023 May;58(5):481-493. doi: 10.1007/s00535-023-01970-3. Epub 2023 Mar 16.
3
The association between hepatitis B mutants and hepatocellular carcinoma: A meta-analysis.
Medicine (Baltimore). 2017 May;96(19):e6835. doi: 10.1097/MD.0000000000006835.
4
Hepatitis B Management in the Pregnant Patient: An Update.
J Clin Transl Hepatol. 2016 Sep 28;4(3):241-247. doi: 10.14218/JCTH.2016.00014. Epub 2016 Sep 25.
5
Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma.
Nat Commun. 2016 Oct 5;7:12992. doi: 10.1038/ncomms12992.
6
Management of HBV and HBV/HDV-Associated Liver Cirrhosis.
Visc Med. 2016 Apr;32(2):86-94. doi: 10.1159/000445518. Epub 2016 Apr 12.
7
Precore/core region mutations of hepatitis B virus related to clinical severity.
World J Gastroenterol. 2016 May 7;22(17):4287-96. doi: 10.3748/wjg.v22.i17.4287.
10
Role of Sex Hormones in the Development and Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Int J Endocrinol. 2015;2015:854530. doi: 10.1155/2015/854530. Epub 2015 Sep 27.

本文引用的文献

2
Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase.
Clin Gastroenterol Hepatol. 2010 Jun;8(6):535-40. doi: 10.1016/j.cgh.2010.03.006. Epub 2010 Mar 19.
3
Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
J Natl Cancer Inst. 2009 Aug 5;101(15):1066-82. doi: 10.1093/jnci/djp180. Epub 2009 Jul 2.
5
Hepatitis B virus infection.
Lancet. 2009 Feb 14;373(9663):582-92. doi: 10.1016/S0140-6736(09)60207-5.
7
Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.
J Natl Cancer Inst. 2008 Aug 20;100(16):1134-43. doi: 10.1093/jnci/djn243. Epub 2008 Aug 11.
10
Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.
J Infect Dis. 2006 May 1;193(9):1258-65. doi: 10.1086/502978. Epub 2006 Apr 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验